Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


26.11.2018

1 BMC Cancer
1 Br J Surg
1 Clin Cancer Res
2 Clin Res Hepatol Gastroenterol
1 Dig Dis
2 Dis Colon Rectum
1 Gut
1 Int J Cancer
2 Int J Colorectal Dis
1 J Am Coll Surg
1 Oncol Rep
1 PLoS One
5 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. KASPER S, Kisro J, Fuchs M, Muller C, et al
    Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
    BMC Cancer. 2018;18:1124.
    PubMed     Text format     Abstract available


    Br J Surg

  2. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
    Sex differences in faecal occult blood test screening for colorectal cancer.
    Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. PARK SY, Kim JY, Choi JH, Kim JH, et al
    Inhibition of LEF1-mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
    Clin Cancer Res. 2018 Nov 16. pii: 1078-0432.CCR-18-1232.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  4. ZHANG J, Fu Y, Chen J, Li Q, et al
    Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population.
    Clin Res Hepatol Gastroenterol. 2018 Nov 14. pii: S2210-7401(18)30229.
    PubMed     Text format     Abstract available

  5. LAMY S, Guimbaud R, Digue L, Cirilo-Cassaigne I, et al
    Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study.
    Clin Res Hepatol Gastroenterol. 2018 Nov 14. pii: S2210-7401(18)30224.
    PubMed     Text format     Abstract available


    Dig Dis

  6. SCHNEIDER J, Koullouros M, Mackay C, Ramsay G, et al
    Is Liver Ultrasound Useful as Part of the Surveillance Strategy following Potentially Curative Colorectal Cancer Resection?
    Dig Dis. 2018 Nov 22:1-5. doi: 10.1159/000495114.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  7. NISHIKAWA T, Nozawa H, Kawai K, Sasaki K, et al
    Short- and Long-term Outcomes of Minimally Invasive Versus Open Multivisceral Resection for Locally Advanced Colorectal Cancer.
    Dis Colon Rectum. 2018 Nov 15. doi: 10.1097/DCR.0000000000001255.
    PubMed     Text format     Abstract available

  8. ALAVI K
    Systematic Reviews and Meta-analytic Methods: Not All Are Created Equal.
    Dis Colon Rectum. 2018;61:1241-1242.
    PubMed     Text format    


    Gut

  9. LADABAUM U
    Occult blood in faeces: a window into health beyond the colorectum?
    Gut. 2018;67:2079-2080.
    PubMed     Text format    


    Int J Cancer

  10. EIDE PW, Eilertsen IA, Sveen A, Lothe RA, et al
    Long non-coding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.
    Int J Cancer. 2018 Nov 17. doi: 10.1002/ijc.31998.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  11. AL-HUSSEINI MJ, Saad AM, Jazieh KA, Elmatboly AM, et al
    Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
    Int J Colorectal Dis. 2018 Nov 15. pii: 10.1007/s00384-018-3195.
    PubMed     Text format     Abstract available

  12. WROBEL P, Ahmed S
    Current status of immunotherapy in metastatic colorectal cancer.
    Int J Colorectal Dis. 2018 Nov 21. pii: 10.1007/s00384-018-3202.
    PubMed     Text format     Abstract available


    J Am Coll Surg

  13. KANG R, Seath BE, Huang V, Barth RJ Jr, et al
    Impact of Autologous Blood Transfusion on Survival and Recurrence Among Patients Undergoing Partial Hepatectomy for Colorectal Cancer Liver Metastases.
    J Am Coll Surg. 2018 Nov 15. pii: S1072-7515(18)32157.
    PubMed     Text format     Abstract available


    Oncol Rep

  14. WEI HT, Guo EN, Liao XW, Chen LS, et al
    Genomescale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Oncol Rep. 2018;40:1947-1958.
    PubMed     Text format     Abstract available


    PLoS One

  15. MENG C, Yin X, Liu J, Tang K, et al
    TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
    PLoS One. 2018;13:e0207039.
    PubMed     Text format     Abstract available


    World J Surg

  16. MENAHEM B, Lubrano J, Vallois A, Alves A, et al
    Early Closure of Defunctioning Loop Ileostomy: Is It Beneficial for the Patient? A Meta-analysis.
    World J Surg. 2018;42:3171-3178.
    PubMed     Text format     Abstract available

  17. NISHIGORI H, Ishii M, Kokado Y, Fujimoto K, et al
    Effectiveness of Pelvic Floor Rehabilitation for Bowel Dysfunction After Intersphincteric Resection for Lower Rectal Cancer.
    World J Surg. 2018;42:3415-3421.
    PubMed     Text format     Abstract available

  18. INOUE Y, Fujii K, Tashiro K, Ishii M, et al
    Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis.
    World J Surg. 2018;42:3316-3330.
    PubMed     Text format     Abstract available

  19. ALLAIX ME, Furnee E, Esposito L, Mistrangelo M, et al
    Analysis of Early and Long-Term Oncologic Outcomes After Converted Laparoscopic Resection Compared to Primary Open Surgery for Rectal Cancer.
    World J Surg. 2018;42:3405-3414.
    PubMed     Text format     Abstract available

  20. ARJONA-SANCHEZ A, Rufian-Pena S, Sanchez-Hidalgo JM, Casado-Adam A, et al
    Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience.
    World J Surg. 2018;42:3120-3124.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: